nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—CHRM3—ureter—uterine cancer	0.127	0.412	CbGeAlD
Trihexyphenidyl—Parotitis—Etoposide—uterine cancer	0.125	0.181	CcSEcCtD
Trihexyphenidyl—CHRM3—muscle of abdomen—uterine cancer	0.0915	0.297	CbGeAlD
Trihexyphenidyl—Chorea—Progesterone—uterine cancer	0.0843	0.122	CcSEcCtD
Trihexyphenidyl—Forgetfulness—Progesterone—uterine cancer	0.0843	0.122	CcSEcCtD
Trihexyphenidyl—CHRM3—exocrine gland—uterine cancer	0.025	0.0813	CbGeAlD
Trihexyphenidyl—Paranoia—Medroxyprogesterone Acetate—uterine cancer	0.0235	0.0339	CcSEcCtD
Trihexyphenidyl—Memory impairment—Progesterone—uterine cancer	0.0225	0.0325	CcSEcCtD
Trihexyphenidyl—CHRM5—epithelium—uterine cancer	0.0195	0.0632	CbGeAlD
Trihexyphenidyl—Euphoric mood—Medroxyprogesterone Acetate—uterine cancer	0.0137	0.0199	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Medroxyprogesterone Acetate—uterine cancer	0.0113	0.0164	CcSEcCtD
Trihexyphenidyl—Dry skin—Medroxyprogesterone Acetate—uterine cancer	0.0106	0.0154	CcSEcCtD
Trihexyphenidyl—CHRM3—smooth muscle tissue—uterine cancer	0.0105	0.0341	CbGeAlD
Trihexyphenidyl—CHRM3—renal system—uterine cancer	0.0101	0.0328	CbGeAlD
Trihexyphenidyl—Weight decreased—Progesterone—uterine cancer	0.01	0.0145	CcSEcCtD
Trihexyphenidyl—Drowsiness—Progesterone—uterine cancer	0.00988	0.0143	CcSEcCtD
Trihexyphenidyl—Blindness—Epirubicin—uterine cancer	0.00915	0.0132	CcSEcCtD
Trihexyphenidyl—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.00908	0.0131	CcSEcCtD
Trihexyphenidyl—CHRM1—female reproductive system—uterine cancer	0.00904	0.0293	CbGeAlD
Trihexyphenidyl—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00895	0.0129	CcSEcCtD
Trihexyphenidyl—Blindness—Doxorubicin—uterine cancer	0.00846	0.0122	CcSEcCtD
Trihexyphenidyl—CHRM3—female reproductive system—uterine cancer	0.00809	0.0263	CbGeAlD
Trihexyphenidyl—Tension—Progesterone—uterine cancer	0.00758	0.0109	CcSEcCtD
Trihexyphenidyl—Nervousness—Progesterone—uterine cancer	0.0075	0.0108	CcSEcCtD
Trihexyphenidyl—CHRM3—female gonad—uterine cancer	0.00736	0.0239	CbGeAlD
Trihexyphenidyl—Vision blurred—Progesterone—uterine cancer	0.00728	0.0105	CcSEcCtD
Trihexyphenidyl—Tension—Medroxyprogesterone Acetate—uterine cancer	0.00686	0.00992	CcSEcCtD
Trihexyphenidyl—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00679	0.00982	CcSEcCtD
Trihexyphenidyl—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00643	0.00929	CcSEcCtD
Trihexyphenidyl—Confusional state—Progesterone—uterine cancer	0.00635	0.00918	CcSEcCtD
Trihexyphenidyl—Tachycardia—Progesterone—uterine cancer	0.00615	0.00889	CcSEcCtD
Trihexyphenidyl—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00576	0.00832	CcSEcCtD
Trihexyphenidyl—Somnolence—Progesterone—uterine cancer	0.0056	0.0081	CcSEcCtD
Trihexyphenidyl—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00557	0.00805	CcSEcCtD
Trihexyphenidyl—Constipation—Progesterone—uterine cancer	0.00539	0.00779	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Progesterone—uterine cancer	0.00519	0.0075	CcSEcCtD
Trihexyphenidyl—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00508	0.00734	CcSEcCtD
Trihexyphenidyl—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00488	0.00706	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.0047	0.0068	CcSEcCtD
Trihexyphenidyl—Asthenia—Progesterone—uterine cancer	0.00452	0.00653	CcSEcCtD
Trihexyphenidyl—Dizziness—Progesterone—uterine cancer	0.00417	0.00602	CcSEcCtD
Trihexyphenidyl—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.0041	0.00592	CcSEcCtD
Trihexyphenidyl—Vomiting—Progesterone—uterine cancer	0.00401	0.00579	CcSEcCtD
Trihexyphenidyl—Rash—Progesterone—uterine cancer	0.00397	0.00574	CcSEcCtD
Trihexyphenidyl—Dermatitis—Progesterone—uterine cancer	0.00397	0.00574	CcSEcCtD
Trihexyphenidyl—Headache—Progesterone—uterine cancer	0.00395	0.0057	CcSEcCtD
Trihexyphenidyl—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00378	0.00546	CcSEcCtD
Trihexyphenidyl—Nausea—Progesterone—uterine cancer	0.00374	0.00541	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Dactinomycin—uterine cancer	0.00367	0.0053	CcSEcCtD
Trihexyphenidyl—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00363	0.00525	CcSEcCtD
Trihexyphenidyl—Rash—Medroxyprogesterone Acetate—uterine cancer	0.0036	0.0052	CcSEcCtD
Trihexyphenidyl—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.0036	0.0052	CcSEcCtD
Trihexyphenidyl—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00358	0.00517	CcSEcCtD
Trihexyphenidyl—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00339	0.0049	CcSEcCtD
Trihexyphenidyl—Dry skin—Epirubicin—uterine cancer	0.00337	0.00487	CcSEcCtD
Trihexyphenidyl—Confusional state—Etoposide—uterine cancer	0.00325	0.0047	CcSEcCtD
Trihexyphenidyl—Asthenia—Dactinomycin—uterine cancer	0.0032	0.00462	CcSEcCtD
Trihexyphenidyl—Tachycardia—Etoposide—uterine cancer	0.00315	0.00455	CcSEcCtD
Trihexyphenidyl—Dry skin—Doxorubicin—uterine cancer	0.00312	0.00451	CcSEcCtD
Trihexyphenidyl—Weight decreased—Epirubicin—uterine cancer	0.00287	0.00415	CcSEcCtD
Trihexyphenidyl—Somnolence—Etoposide—uterine cancer	0.00287	0.00414	CcSEcCtD
Trihexyphenidyl—Drowsiness—Epirubicin—uterine cancer	0.00283	0.00409	CcSEcCtD
Trihexyphenidyl—Vomiting—Dactinomycin—uterine cancer	0.00283	0.00409	CcSEcCtD
Trihexyphenidyl—Rash—Dactinomycin—uterine cancer	0.00281	0.00406	CcSEcCtD
Trihexyphenidyl—Constipation—Etoposide—uterine cancer	0.00276	0.00398	CcSEcCtD
Trihexyphenidyl—Weight decreased—Doxorubicin—uterine cancer	0.00266	0.00384	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Etoposide—uterine cancer	0.00266	0.00384	CcSEcCtD
Trihexyphenidyl—Nausea—Dactinomycin—uterine cancer	0.00265	0.00382	CcSEcCtD
Trihexyphenidyl—Drowsiness—Doxorubicin—uterine cancer	0.00262	0.00379	CcSEcCtD
Trihexyphenidyl—Asthenia—Etoposide—uterine cancer	0.00231	0.00334	CcSEcCtD
Trihexyphenidyl—Tension—Epirubicin—uterine cancer	0.00217	0.00314	CcSEcCtD
Trihexyphenidyl—Nervousness—Epirubicin—uterine cancer	0.00215	0.00311	CcSEcCtD
Trihexyphenidyl—Dizziness—Etoposide—uterine cancer	0.00213	0.00308	CcSEcCtD
Trihexyphenidyl—Vision blurred—Epirubicin—uterine cancer	0.00209	0.00302	CcSEcCtD
Trihexyphenidyl—Vomiting—Etoposide—uterine cancer	0.00205	0.00296	CcSEcCtD
Trihexyphenidyl—Agitation—Epirubicin—uterine cancer	0.00203	0.00294	CcSEcCtD
Trihexyphenidyl—Rash—Etoposide—uterine cancer	0.00203	0.00294	CcSEcCtD
Trihexyphenidyl—Dermatitis—Etoposide—uterine cancer	0.00203	0.00293	CcSEcCtD
Trihexyphenidyl—Headache—Etoposide—uterine cancer	0.00202	0.00292	CcSEcCtD
Trihexyphenidyl—Tension—Doxorubicin—uterine cancer	0.00201	0.00291	CcSEcCtD
Trihexyphenidyl—Nervousness—Doxorubicin—uterine cancer	0.00199	0.00288	CcSEcCtD
Trihexyphenidyl—Vision blurred—Doxorubicin—uterine cancer	0.00193	0.00279	CcSEcCtD
Trihexyphenidyl—Nausea—Etoposide—uterine cancer	0.00191	0.00277	CcSEcCtD
Trihexyphenidyl—Agitation—Doxorubicin—uterine cancer	0.00188	0.00272	CcSEcCtD
Trihexyphenidyl—Confusional state—Epirubicin—uterine cancer	0.00182	0.00263	CcSEcCtD
Trihexyphenidyl—Tachycardia—Epirubicin—uterine cancer	0.00176	0.00255	CcSEcCtD
Trihexyphenidyl—Confusional state—Doxorubicin—uterine cancer	0.00169	0.00244	CcSEcCtD
Trihexyphenidyl—Tachycardia—Doxorubicin—uterine cancer	0.00163	0.00236	CcSEcCtD
Trihexyphenidyl—Somnolence—Epirubicin—uterine cancer	0.00161	0.00232	CcSEcCtD
Trihexyphenidyl—Constipation—Epirubicin—uterine cancer	0.00154	0.00223	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Epirubicin—uterine cancer	0.00149	0.00215	CcSEcCtD
Trihexyphenidyl—Somnolence—Doxorubicin—uterine cancer	0.00149	0.00215	CcSEcCtD
Trihexyphenidyl—Constipation—Doxorubicin—uterine cancer	0.00143	0.00207	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Doxorubicin—uterine cancer	0.00138	0.00199	CcSEcCtD
Trihexyphenidyl—Asthenia—Epirubicin—uterine cancer	0.0013	0.00187	CcSEcCtD
Trihexyphenidyl—Asthenia—Doxorubicin—uterine cancer	0.0012	0.00173	CcSEcCtD
Trihexyphenidyl—Dizziness—Epirubicin—uterine cancer	0.00119	0.00173	CcSEcCtD
Trihexyphenidyl—Vomiting—Epirubicin—uterine cancer	0.00115	0.00166	CcSEcCtD
Trihexyphenidyl—Rash—Epirubicin—uterine cancer	0.00114	0.00165	CcSEcCtD
Trihexyphenidyl—Dermatitis—Epirubicin—uterine cancer	0.00114	0.00164	CcSEcCtD
Trihexyphenidyl—Headache—Epirubicin—uterine cancer	0.00113	0.00164	CcSEcCtD
Trihexyphenidyl—Dizziness—Doxorubicin—uterine cancer	0.00111	0.0016	CcSEcCtD
Trihexyphenidyl—Nausea—Epirubicin—uterine cancer	0.00107	0.00155	CcSEcCtD
Trihexyphenidyl—Vomiting—Doxorubicin—uterine cancer	0.00106	0.00154	CcSEcCtD
Trihexyphenidyl—Rash—Doxorubicin—uterine cancer	0.00105	0.00152	CcSEcCtD
Trihexyphenidyl—Dermatitis—Doxorubicin—uterine cancer	0.00105	0.00152	CcSEcCtD
Trihexyphenidyl—Headache—Doxorubicin—uterine cancer	0.00105	0.00151	CcSEcCtD
Trihexyphenidyl—Nausea—Doxorubicin—uterine cancer	0.000993	0.00144	CcSEcCtD
